Company Encyclopedia
View More
name
CR MEDICAL
01515.HK
China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, hospital management, and other hospital-related services in the People’s Republic of China. It operates through two segments Hospital and Other Business. The Hospital segment offers out-patient and in-patient business corresponding to self-owned hospitals. The Other Business segment offers operation management services, supply chain services, and other services to participating hospitals and IOT/OT hospitals.
34.20 B
01515.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care FacilitiesIndustry
Industry Ranking4/18
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE7.47%B
    • Profit Margin5.01%C
    • Gross Margin15.75%D
  • Growth ScoreC
    • Revenue YoY-5.54%D
    • Net Profit YoY60.62%B
    • Total Assets YoY0.87%C
    • Net Assets YoY6.23%B
  • Cash ScoreC
    • Cash Flow Margin1994.55%A
    • OCF YoY-5.54%D
  • Operating ScoreB
    • Turnover0.69B
  • Debt ScoreC
    • Gearing Ratio42.82%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CITIC Construction Investment: Maintains "Buy" rating on CR MEDICAL, expects revenue growth in 25H2 to continue the trend of 25H1

    CITIC Construction Investment maintains a "Buy" rating on CR MEDICAL, expecting revenues of 9 billion, 9.199 billion, and 9.404 billion yuan for 2025-2027, respectively. In the first half of 2025, revenue was 4.525 billion yuan, a year-on-year decrease of 9.1%; net profit was 374 million yuan, a year-on-year decrease of 26.9%. The company will distribute an interim dividend of 0.05 yuan per share, and it is expected that the revenue growth rate in the second half of the year will continue the trend of the first half. In the future, attention will be paid to the high-quality development plan for state-owned enterprises in healthcare to seize industry consolidation opportunities

    Zhitong·
    HK
    01515
    0.00%
    Zhitong·
    HK
    01515
    0.00%

    "Performance" CR MEDICAL's mid-term net profit of 340 million RMB fell by 21.8%, with a dividend of 5 cents

    CR MEDICAL announced its interim results for the six months ending in June, with revenue of RMB 4.525 billion, a year-on-year decrease of 9.1%. It recorded a net profit of RMB 340 million, down 21.8%, with earnings per share of 27 cents. The interim dividend remains at 5 cents

    AASTOCKS·
    HK
    01515
    0.00%
    AASTOCKS·
    HK
    01515
    0.00%

    CR MEDICAL released its interim results, with shareholders' profit attributable to them at HKD 340 million, a year-on-year decrease of 21.76%

    CR MEDICAL released its interim results for the period ending June 30, 2025, with revenue of CNY 4.525 billion, a year-on-year decrease of 9.07%; profit attributable to shareholders was CNY 340 million, a year-on-year decrease of 21.76%. The basic earnings per share were CNY 0.27, and an interim dividend of CNY 0.05 per share is proposed. The hospital business segment's revenue was CNY 4.259 billion, a year-on-year decrease of 7.4%. The group manages a total of 103 medical institutions across 10 provinces and cities in China

    Zhitong·
    HK
    01515
    0.00%
    Zhitong·
    HK
    01515
    0.00%

    CR MEDICAL: Dan Baojie resigns as executive director

    According to the announcement from CR MEDICAL, Mr. Dan Baojie has resigned from his position as Executive Director due to other work arrangements, effective from August 26, 2025. Following Mr. Dan's resignation as Executive Director on the same date, he will also no longer serve as the company's Vice President

    Zhitong·
    HK
    01515
    0.00%
    Zhitong·
    HK
    01515
    0.00%

    Zhitong Hong Kong Stock Connect Proportion Anomaly Statistics | August 11

    According to the data on August 8, 2025, the Hong Kong Stock Connect shareholding ratios of Jingtai Holdings, Anjuke Food, and Lepu Biotech-B increased by 1.84%, 1.23%, and 1.08%, respectively. Meanwhile, the shareholding ratios of Longpan Technology, Beijing Mechanical and Electrical Co., Ltd., and Haotian International Construction Investment decreased by 2.72%, 2.06%, and 0.98%, respectively. In the last 5 trading days, the shareholding ratios of Meizhong Jiahe, CR MEDICAL, and YOFC increased by 7.19%, 3.57%, and 3.39%, respectively; while the shareholding ratios of Yisou Technology, Longpan Technology, and Chongqing Iron and Steel Co., Ltd. decreased by 10.93%, 5.28%, and 3.84%, respectively

    Zhitong·
    SH
    601869
    +1.20%
    HK
    06869
    +0.75%
    HK
    01515
    0.00%
    Zhitong·
    SH
    601869
    +1.20%
    HK
    06869
    +0.75%
    HK
    01515
    0.00%
    © 2025 Longbridge｜Disclaimer